205 research outputs found
Survey of the rate of PSA testing in general practice
The use of prostate specific antigen (PSA) test could have a large impact on the incidence of prostate cancer in the UK. Over a period of 1 year (1999), 3.5% out of 160 015 men aged > 45 on a GP database, who had no previous record of prostate cancer, had a PSA test. Of the tested men, 21.3% had a PSA > 4 ng/ml. Future data need to distinguish between men with and without symptoms. © 2001 Cancer Research Campaign http://www.bjcancer.co
Participation of women scientists in ESA solar system missions: A historical trend
We analyzed the participation of women scientists in 10 ESA (European Space Agency) Solar System missions over a period of 38 years. Being part of a spacecraft mission science team can be considered a proxy to measure the "success"in the field. Participation of women in PI (Principal Investigators) teams varied between 4% and 25 %, with several missions with no women as PI. The percentage of female scientists as Co-I (Co-Investigators) is always less than 16 %. This number is lower than the percentage of women in the International Astronomical Union from all ESA's Member State (24 %), which can give us an indication of the percentage of women in the field. We encountered many difficulties to gather the data for this study. The list of team members were not always easily accessible. An additional difficulty was to determine the percentage of female scientists in planetary science in Europe. We would like to encourage the planetary community as a whole, as well as international organizations, universities and societies to continuously gather statistics over many years. Detailed statistics are only the first step to closely monitor the development of achievement gaps and initiate measures to tackle potential causes of inequity, leading to gender inequalities in STEM careers
Vitamin B12 Deficiency Alters the Gut Microbiota in a Murine Model of Colitis
Purpose: Inflammatory bowel disease (IBD) refers to a spectrum of autoimmune diseases, which result in chronic intestinal inflammation. Previous findings suggest a role for diet, nutrition and dysbiosis of the gut microbiota in both the development and progression of the condition. Vitamin B12 is a key cofactor of methionine synthase and is produced solely by microbes. Previous work links increased levels of homocysteine, a substrate of methionine synthase, MetH, to IBD indicating a potential role for vitamin B12 deficiency in intestinal injury and inflammation. This study assessed the role of vitamin B12 in shaping the gut microbiota and determining responses to intestinal injury using a reproducible murine model of colitis.
Methods: The effects of vitamin B12 supplementation and deficiency were assessed in vivo; 3-week-old post-weanling C57Bl/6 mice were divided into three dietary treatment groups: (1) sufficient vitamin B12 (50 mg/Kg), (2) deficient vitamin B12 (0 mg/Kg) and (3) supplemented vitamin B12 (200 mg/Kg) for a period of 4 weeks. Intestinal injury was induced with 2% dextran sodium sulphate (DSS) via drinking water for 5 days. The impact of varying levels of dietary vitamin B12 on gut microbiota composition was assessed using 16S rRNA gene sequencing from fecal samples collected at day 0 and day 28 of the dietary intervention, and 7 days following induction of colitis on day 38, when blood and colonic tissues were also collected.
Results: No significant alterations were found in the gut microbiota composition of disease-free animals in response to dietary interventions. By contrast, after DSS-induced colitis, >30 genera were significantly altered in vitamin B12 deficient mice. Altered B12 levels produced no significant effect on composite disease-activity scores; however, administration of a B12 deficient diet resulted in reduced DSS-induced epithelial tissue damage.
Conclusions: Vitamin B12 supplementation does not alter the gut microbiota composition under healthy conditions, but does contribute to differential microbial responses and intestinal dysbiosis following the induction of experimental colitis
Winter is coming : nightmares and sleep problems during seasonal affective disorder
Sleep problems, especially nightmares and insomnia, often accompany depression. This study investigated how nightmares, symptoms of insomnia, chronotype and sleep duration associate with seasonal affective disorder, a special form of depression. Additionally, it was noted how latitude, a proxy for photoperiod, and characteristics of the place of residence affect the prevalence of seasonal affective disorder and sleep problems. To study these questions, data from FINRISK 2012 study were used. FINRISK 2012 consists of a random population sample of Finnish adults aged 25-74 years (n = 4905) collected during winter from Finnish urban and rural areas spanning the latitudes of 60 degrees N to 66 degrees N. The Seasonal Pattern Assessment Questionnaire was used to assess symptoms of seasonal affective disorder. Participants with symptoms of seasonal affective disorder had significantly increased odds of experiencing frequent nightmares and symptoms of insomnia, and they were more often evening chronotypes. Associations between latitude, population size and urbanicity with seasonal affective disorder symptoms and sleep disturbances were generally not significant, although participants living in areas bordering urban centres had less sleep problems than participants from other regions. These data show that the prevalence of seasonal affective disorder was not affected by latitude.Peer reviewe
Analysis of glycoprotein processing in the endoplasmic reticulum using synthetic oligosaccharides
Protein quality control (QC) in the endoplasmic reticulum (ER) comprises many steps, including folding and transport of nascent proteins as well as degradation of misfolded proteins. Recent studies have revealed that high-mannose-type glycans play a pivotal role in the QC process. To gain knowledge about the molecular basis of this process with well-defined homogeneous compounds, we achieved a convergent synthesis of high-mannose-type glycans and their functionalized derivatives. We focused on analyses of UDP-Glc: glycoprotein glucosyltransferase (UGGT) and ER Glucosidase II, which play crucial roles in glycoprotein QC; however, their specificities remain unclear. In addition, we established an in vitro assay system mimicking the in vivo condition which is highly crowded because of the presence of various biomacromolecules
A Structure-Based Approach for Detection of Thiol Oxidoreductases and Their Catalytic Redox-Active Cysteine Residues
Cysteine (Cys) residues often play critical roles in proteins, for example, in
the formation of structural disulfide bonds, metal binding, targeting proteins
to the membranes, and various catalytic functions. However, the structural
determinants for various Cys functions are not clear. Thiol oxidoreductases,
which are enzymes containing catalytic redox-active Cys residues, have been
extensively studied, but even for these proteins there is little understanding
of what distinguishes their catalytic redox Cys from other Cys functions.
Herein, we characterized thiol oxidoreductases at a structural level and
developed an algorithm that can recognize these enzymes by (i) analyzing amino
acid and secondary structure composition of the active site and its similarity
to known active sites containing redox Cys and (ii) calculating accessibility,
active site location, and reactivity of Cys. For proteins with known or modeled
structures, this method can identify proteins with catalytic Cys residues and
distinguish thiol oxidoreductases from the enzymes containing other catalytic
Cys types. Furthermore, by applying this procedure to Saccharomyces
cerevisiae proteins containing conserved Cys, we could identify the
majority of known yeast thiol oxidoreductases. This study provides insights into
the structural properties of catalytic redox-active Cys and should further help
to recognize thiol oxidoreductases in protein sequence and structure
databases
Heterozygous loss of function of IQSEC2/Iqsec2 leads to increased activated Arf6 and severe neurocognitive seizure phenotype in females
Clinical presentations of mutations in the IQSEC2 gene on the X-chromosome initially implicated to cause non-syndromic intellectual disability (ID) in males have expanded to include early onset seizures in males as well as in females. The molecular pathogenesis is not well understood, nor the mechanisms driving disease expression in heterozygous females. Using a CRISPR/Cas9-edited Iqsec2 KO mouse model, we confirm the loss of Iqsec2 mRNA expression and lack of Iqsec2 protein within the brain of both founder and progeny mice. Both male (52%) and female (46%) Iqsec2 KO mice present with frequent and recurrent seizures. Focusing on Iqsec2 KO heterozygous female mice, we demonstrate increased hyperactivity, altered anxiety and fear responses, decreased social interactions, delayed learning capacity and decreased memory retention/novel recognition, recapitulating psychiatric issues, autistic-like features, and cognitive deficits present in female patients with loss-of-function IQSEC2 variants. Despite Iqsec2 normally acting to activate Arf6 substrate, we demonstrate that mice modelling the loss of Iqsec2 function present with increased levels of activated Arf6. We contend that loss of Iqsec2 function leads to altered regulation of activated Arf6-mediated responses to synaptic signalling and immature synaptic networks. We highlight the importance of IQSEC2 function for females by reporting a novel nonsense variant c.566C > A, p.(S189*) in an elderly female patient with profound intellectual disability, generalised seizures, and behavioural disturbances. Our human and mouse data reaffirm IQSEC2 as another disease gene with an unexpected X-chromosome heterozygous female phenotype. Our Iqsec2 mouse model recapitulates the phenotypes observed in human patients despite the differences in the IQSEC2/Iqsec2 gene X-chromosome inactivation between the species.Peer reviewe
- …